Medical Technology Company President Convicted in $77 Million COVID-19 and Allergy Testing Scheme

A federal jury convicted the president of a Silicon Valley-based medical technology company today of participating in a scheme to mislead investors, commit health care fraud, and pay illegal kickbacks in connection with the submission of over $77 million in false and fraudulent claims for COVID-19 and allergy testing.